Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2002 Holcombe Blvd
Houston, TX 77030Phone+1 713-791-1414- Is this information wrong?
Education & Training
- Baylor College of MedicineFellowship, Infectious Disease, 2002 - 2005
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2000 - 2002
- McGovern Medical School at UTHealthClass of 2000
Certifications & Licensure
- TX State Medical License 2001 - 2024
- NY State Medical License 2006 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsThe activity of the diaminopyrimidine dihydrofolate reducatase inhibitor, iclaprim, against Toxoplasma gondii in an in vitro model: a pilot study.David B. Huang> ;Diagnostic Microbiology and Infectious Disease. 2021 Apr 1
- In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018.David B. Huang, Leonard R. Duncan, Yahse K. Edah, Paul R. Rhomberg, Robert K. Flamm, Michael D. Huband> ;Journal of Global Antimicrobial Resistance. 2021 Mar 1
- Comparison of Newer Intraocular Lens Power Calculation Methods for Eyes after Corneal Refractive Surgery.Wang, L.,Tang, M.,Huang, D.,Weikert, M. P.,Koch, D. D.> ;Ophthalmology. 2015 Oct 16
- Join now to see all
Authored Content
- A Pooled Analysis of the Phase 3 REVIVE Trials: Randomized, Double-Blind Studies to EValuate the Safety and Efficacy of Iclaprim Versus Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure InfectionsMay 2018
- A Pooled Analysis of the Phase 3 REVIVE Trials: Randomized, Double-Blind Studies to EValuate the Safety and Efficacy of Iclaprim Versus Vancomycin for trEatment of Acute Bacterial Skin and Skin Structure InfectionsMay 2018
Hospital Affiliations
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: